LOADING
Comparing Mastercard Inc (MA) and Johnson & Johnson (JNJ) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $481.8B | $617.0B |
| P/E Ratio | 30.3 | 30.0 |
| Forward P/E | 24.2 | 21.0 |
| PEG Ratio | 1.46 | 2.82 |
| EPS | $18.15 | $8.53 |
| Revenue Growth (YoY) | 14.1% | 6.6% |
| Profit Margin | 46.3% | 21.5% |
| Return on Equity | 241.2% | 25.7% |
| Dividend Yield | 0.61% | 2.03% |
| Beta | 0.73 | 0.23 |
| 52-Week High | $601.23 | $281.07 |
| 52-Week Low | $463.74 | $178.89 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.